Mohammad Azab
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Epigenetics and DNA Methylation 15
- Histone Deacetylase Inhibitors Research 7
- RNA modifications and cancer 5
- Hematology 11
- Acute Myeloid Leukemia Research 11
- Co-authors
- Omar F. Khabour (11 shared papers)Karem H. Alzoubi (11 shared papers)Pietro Taverna (19 shared papers)Thomas Eissenberg (4 shared papers)May F. Sadiq (2 shared papers)Gavin Choy (12 shared papers)Aram Oganesian (7 shared papers)Sanjeev Redkar (5 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (6 papers)Blood (5 papers)Clinical Cancer Research (3 papers)Nicotine & Tobacco Research (3 papers)
- Partner nations
- United StatesJordanItaly
In The Last Decade
Mohammad Azab
45 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 107
- Hematology 128
- Cancer Research 132
- Physiology 191
- Molecular Biology 436
- Oncology 129
Countries citing papers authored by Mohammad Azab
This map shows the geographic impact of Mohammad Azab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Azab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Azab more than expected).
Fields of papers citing papers by Mohammad Azab
This network shows the impact of papers produced by Mohammad Azab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Azab. The network helps show where Mohammad Azab may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Azab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 93 | |
| 2 | 2010 | 83 | |
| 3 | 2014 | 81 | |
| 4 | 2020 | 80 | |
| 5 | 2010 | 69 | |
| 6 | 2014 | 66 | |
| 7 | 2016 | 66 | |
| 8 | 2013 | 55 | |
| 9 | 2012 | 52 | |
| 10 | 2012 | 48 | |
| 11 | 2018 | 46 | |
| 12 | 2014 | 29 | |
| 13 | 2018 | 26 | |
| 14 | 2015 | 25 | |
| 15 | 2012 | 25 | |
| 16 | 2019 | 21 | |
| 17 | 2014 | 20 | |
| 18 | 2013 | 19 | |
| 19 | 2016 | 19 | |
| 20 | 2018 | 19 |
About Mohammad Azab
Mohammad Azab is a scholar working on Molecular Biology, Hematology, Cancer Research, Oncology and Physiology, having authored 47 papers that have together received 1.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (15 papers), Acute Myeloid Leukemia Research (11 papers), Histone Deacetylase Inhibitors Research (7 papers), Smoking Behavior and Cessation (6 papers), Carcinogens and Genotoxicity Assessment (6 papers), RNA modifications and cancer (5 papers), Ovarian cancer diagnosis and treatment (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Hematology (128 citations), Cancer Research (132 citations), Physiology (191 citations), Molecular Biology (436 citations) and Oncology (129 citations). Mohammad Azab has collaborated with scholars based in United States, Jordan and Italy. Frequent co-authors include Omar F. Khabour, Karem H. Alzoubi, Pietro Taverna, Thomas Eissenberg, May F. Sadiq, Gavin Choy, Aram Oganesian, Sanjeev Redkar, Brian A. Primack and Faris El‐Dahiyat. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Blood, Clinical Cancer Research and Nicotine & Tobacco Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.